HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon CEO Garcia Resigns Amid Continued Turnaround Challenges

This article was originally published in The Rose Sheet

Executive Summary

The former Colgate-Palmolive exec served less than two years as CEO of Revlon, which continues to be plagued by declining sales and widening losses despite brand revival efforts and investments in e-commerce. There were bright spots in the fourth quarter, including renewed growth in the firm's US color cosmetics business.

You may also be interested in...



Revlon Doubles China Biz, Grows E-Commerce 66%; But Alas, North America

On the bright side in North America, the Revlon brand has reclaimed its lead in the US mass lip segment, and both Revlon and Almay are off to strong starts in the fourth quarter, company leadership says. The firm continues to build the international and digital sides of its business in search of sustainable growth outside of Elizabeth Arden.

Health, Beauty And Wellness News: Revlon CEO, Rodan + Fields Investment

Too Faced fails in appeal of NAD findings; more of same in supplement GMP warnings; vitamin D benefit for in vitro fertilization shown; TropicSport promotes mineral over chemical sunscreens; Rodan + Fields investment by TPG; and Revlon chairman's daughter takes the helm.

Revlon Encouraged By Q4 Progress, But Sustainable Growth Will Take Time

Firm aims to streamlining decision-making for greater speed and agility in local markets, while counting on momentum behind restaged brands and a more regular product launch schedule in fiscal 2018. Meanwhile, its search for a new CEO continues. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel